COVID-19 Impact on Global Pet Veterinary Drug Market Insights, Forecast to 2026
Pet Veterinary Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pet Veterinary Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pet Veterinary Drug market is segmented into
The Pet Veterinary Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pet Veterinary Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pet Veterinary Drug Market Share Analysis
Pet Veterinary Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pet Veterinary Drug business, the date to enter into the Pet Veterinary Drug market, Pet Veterinary Drug product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Pet Veterinary Drug market is segmented into
- Anti-Infectives
- Anti-Inflammatory
- Parasiticides
- Analgesics
- Sedatives
- Others
- Veterinary Hospitals
- Veterinary Clinics
- Drug Stores
The Pet Veterinary Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pet Veterinary Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pet Veterinary Drug Market Share Analysis
Pet Veterinary Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pet Veterinary Drug business, the date to enter into the Pet Veterinary Drug market, Pet Veterinary Drug product introduction, recent developments, etc.
The major vendors covered:
- Boehringer Ingelheim International GmbH
- Zoetis Animal Healthcare
- Bayer AG
- Merck Animal Health
- Elanco Animal Health Inc.
- Virbac Group
- Ceva
- Dechra Pharmaceuticals Plc
- Vetoquinol
- Orion Corporation
1 STUDY COVERAGE
1.1 Pet Veterinary Drug Product Introduction
1.2 Market Segments
1.3 Key Pet Veterinary Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pet Veterinary Drug Market Size Growth Rate by Type
1.4.2 Anti-Infectives
1.4.3 Anti-Inflammatory
1.4.4 Parasiticides
1.4.5 Analgesics
1.4.6 Sedatives
1.4.7 Others
1.5 Market by Application
1.5.1 Global Pet Veterinary Drug Market Size Growth Rate by Application
1.5.2 Veterinary Hospitals
1.5.3 Veterinary Clinics
1.5.4 Drug Stores
1.6 Coronavirus Disease 2019 (Covid-19): Pet Veterinary Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Pet Veterinary Drug Industry
1.6.1.1 Pet Veterinary Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pet Veterinary Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pet Veterinary Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Pet Veterinary Drug Market Size Estimates and Forecasts
2.1.1 Global Pet Veterinary Drug Revenue 2015-2026
2.1.2 Global Pet Veterinary Drug Sales 2015-2026
2.2 Pet Veterinary Drug Market Size by Region: 2020 Versus 2026
2.2.1 Global Pet Veterinary Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pet Veterinary Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PET VETERINARY DRUG COMPETITOR LANDSCAPE BY PLAYERS
3.1 Pet Veterinary Drug Sales by Manufacturers
3.1.1 Pet Veterinary Drug Sales by Manufacturers (2015-2020)
3.1.2 Pet Veterinary Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Pet Veterinary Drug Revenue by Manufacturers
3.2.1 Pet Veterinary Drug Revenue by Manufacturers (2015-2020)
3.2.2 Pet Veterinary Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pet Veterinary Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pet Veterinary Drug Revenue in 2019
3.2.5 Global Pet Veterinary Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pet Veterinary Drug Price by Manufacturers
3.4 Pet Veterinary Drug Manufacturing Base Distribution, Product Types
3.4.1 Pet Veterinary Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pet Veterinary Drug Product Type
3.4.3 Date of International Manufacturers Enter into Pet Veterinary Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Pet Veterinary Drug Market Size by Type (2015-2020)
4.1.1 Global Pet Veterinary Drug Sales by Type (2015-2020)
4.1.2 Global Pet Veterinary Drug Revenue by Type (2015-2020)
4.1.3 Pet Veterinary Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pet Veterinary Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Pet Veterinary Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Pet Veterinary Drug Revenue Forecast by Type (2021-2026)
4.2.3 Pet Veterinary Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pet Veterinary Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Pet Veterinary Drug Market Size by Application (2015-2020)
5.1.1 Global Pet Veterinary Drug Sales by Application (2015-2020)
5.1.2 Global Pet Veterinary Drug Revenue by Application (2015-2020)
5.1.3 Pet Veterinary Drug Price by Application (2015-2020)
5.2 Pet Veterinary Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Pet Veterinary Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Pet Veterinary Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Pet Veterinary Drug Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Pet Veterinary Drug by Country
6.1.1 North America Pet Veterinary Drug Sales by Country
6.1.2 North America Pet Veterinary Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pet Veterinary Drug Market Facts & Figures by Type
6.3 North America Pet Veterinary Drug Market Facts & Figures by Application
7 EUROPE
7.1 Europe Pet Veterinary Drug by Country
7.1.1 Europe Pet Veterinary Drug Sales by Country
7.1.2 Europe Pet Veterinary Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pet Veterinary Drug Market Facts & Figures by Type
7.3 Europe Pet Veterinary Drug Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Pet Veterinary Drug by Region
8.1.1 Asia Pacific Pet Veterinary Drug Sales by Region
8.1.2 Asia Pacific Pet Veterinary Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pet Veterinary Drug Market Facts & Figures by Type
8.3 Asia Pacific Pet Veterinary Drug Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Pet Veterinary Drug by Country
9.1.1 Latin America Pet Veterinary Drug Sales by Country
9.1.2 Latin America Pet Veterinary Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pet Veterinary Drug Market Facts & Figures by Type
9.3 Central & South America Pet Veterinary Drug Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Pet Veterinary Drug by Country
10.1.1 Middle East and Africa Pet Veterinary Drug Sales by Country
10.1.2 Middle East and Africa Pet Veterinary Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pet Veterinary Drug Market Facts & Figures by Type
10.3 Middle East and Africa Pet Veterinary Drug Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Boehringer Ingelheim International GmbH
11.1.1 Boehringer Ingelheim International GmbH Corporation Information
11.1.2 Boehringer Ingelheim International GmbH Description, Business Overview and Total Revenue
11.1.3 Boehringer Ingelheim International GmbH Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Boehringer Ingelheim International GmbH Pet Veterinary Drug Products Offered
11.1.5 Boehringer Ingelheim International GmbH Recent Development
11.2 Zoetis Animal Healthcare
11.2.1 Zoetis Animal Healthcare Corporation Information
11.2.2 Zoetis Animal Healthcare Description, Business Overview and Total Revenue
11.2.3 Zoetis Animal Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Zoetis Animal Healthcare Pet Veterinary Drug Products Offered
11.2.5 Zoetis Animal Healthcare Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Corporation Information
11.3.2 Bayer AG Description, Business Overview and Total Revenue
11.3.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer AG Pet Veterinary Drug Products Offered
11.3.5 Bayer AG Recent Development
11.4 Merck Animal Health
11.4.1 Merck Animal Health Corporation Information
11.4.2 Merck Animal Health Description, Business Overview and Total Revenue
11.4.3 Merck Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Animal Health Pet Veterinary Drug Products Offered
11.4.5 Merck Animal Health Recent Development
11.5 Elanco Animal Health Inc.
11.5.1 Elanco Animal Health Inc. Corporation Information
11.5.2 Elanco Animal Health Inc. Description, Business Overview and Total Revenue
11.5.3 Elanco Animal Health Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Elanco Animal Health Inc. Pet Veterinary Drug Products Offered
11.5.5 Elanco Animal Health Inc. Recent Development
11.6 Virbac Group
11.6.1 Virbac Group Corporation Information
11.6.2 Virbac Group Description, Business Overview and Total Revenue
11.6.3 Virbac Group Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Virbac Group Pet Veterinary Drug Products Offered
11.6.5 Virbac Group Recent Development
11.7 Ceva
11.7.1 Ceva Corporation Information
11.7.2 Ceva Description, Business Overview and Total Revenue
11.7.3 Ceva Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Ceva Pet Veterinary Drug Products Offered
11.7.5 Ceva Recent Development
11.8 Dechra Pharmaceuticals Plc
11.8.1 Dechra Pharmaceuticals Plc Corporation Information
11.8.2 Dechra Pharmaceuticals Plc Description, Business Overview and Total Revenue
11.8.3 Dechra Pharmaceuticals Plc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Dechra Pharmaceuticals Plc Pet Veterinary Drug Products Offered
11.8.5 Dechra Pharmaceuticals Plc Recent Development
11.9 Vetoquinol
11.9.1 Vetoquinol Corporation Information
11.9.2 Vetoquinol Description, Business Overview and Total Revenue
11.9.3 Vetoquinol Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Vetoquinol Pet Veterinary Drug Products Offered
11.9.5 Vetoquinol Recent Development
11.10 Orion Corporation
11.10.1 Orion Corporation Corporation Information
11.10.2 Orion Corporation Description, Business Overview and Total Revenue
11.10.3 Orion Corporation Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Orion Corporation Pet Veterinary Drug Products Offered
11.10.5 Orion Corporation Recent Development
11.1 Boehringer Ingelheim International GmbH
11.1.1 Boehringer Ingelheim International GmbH Corporation Information
11.1.2 Boehringer Ingelheim International GmbH Description, Business Overview and Total Revenue
11.1.3 Boehringer Ingelheim International GmbH Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Boehringer Ingelheim International GmbH Pet Veterinary Drug Products Offered
11.1.5 Boehringer Ingelheim International GmbH Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Pet Veterinary Drug Market Estimates and Projections by Region
12.1.1 Global Pet Veterinary Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Pet Veterinary Drug Revenue Forecast by Regions 2021-2026
12.2 North America Pet Veterinary Drug Market Size Forecast (2021-2026)
12.2.1 North America: Pet Veterinary Drug Sales Forecast (2021-2026)
12.2.2 North America: Pet Veterinary Drug Revenue Forecast (2021-2026)
12.2.3 North America: Pet Veterinary Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Pet Veterinary Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Pet Veterinary Drug Sales Forecast (2021-2026)
12.3.2 Europe: Pet Veterinary Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Pet Veterinary Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pet Veterinary Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pet Veterinary Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pet Veterinary Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pet Veterinary Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Pet Veterinary Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Pet Veterinary Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Pet Veterinary Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Pet Veterinary Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pet Veterinary Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pet Veterinary Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pet Veterinary Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pet Veterinary Drug Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pet Veterinary Drug Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Pet Veterinary Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Pet Veterinary Drug Product Introduction
1.2 Market Segments
1.3 Key Pet Veterinary Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pet Veterinary Drug Market Size Growth Rate by Type
1.4.2 Anti-Infectives
1.4.3 Anti-Inflammatory
1.4.4 Parasiticides
1.4.5 Analgesics
1.4.6 Sedatives
1.4.7 Others
1.5 Market by Application
1.5.1 Global Pet Veterinary Drug Market Size Growth Rate by Application
1.5.2 Veterinary Hospitals
1.5.3 Veterinary Clinics
1.5.4 Drug Stores
1.6 Coronavirus Disease 2019 (Covid-19): Pet Veterinary Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Pet Veterinary Drug Industry
1.6.1.1 Pet Veterinary Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pet Veterinary Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pet Veterinary Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Pet Veterinary Drug Market Size Estimates and Forecasts
2.1.1 Global Pet Veterinary Drug Revenue 2015-2026
2.1.2 Global Pet Veterinary Drug Sales 2015-2026
2.2 Pet Veterinary Drug Market Size by Region: 2020 Versus 2026
2.2.1 Global Pet Veterinary Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pet Veterinary Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PET VETERINARY DRUG COMPETITOR LANDSCAPE BY PLAYERS
3.1 Pet Veterinary Drug Sales by Manufacturers
3.1.1 Pet Veterinary Drug Sales by Manufacturers (2015-2020)
3.1.2 Pet Veterinary Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Pet Veterinary Drug Revenue by Manufacturers
3.2.1 Pet Veterinary Drug Revenue by Manufacturers (2015-2020)
3.2.2 Pet Veterinary Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pet Veterinary Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pet Veterinary Drug Revenue in 2019
3.2.5 Global Pet Veterinary Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pet Veterinary Drug Price by Manufacturers
3.4 Pet Veterinary Drug Manufacturing Base Distribution, Product Types
3.4.1 Pet Veterinary Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pet Veterinary Drug Product Type
3.4.3 Date of International Manufacturers Enter into Pet Veterinary Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Pet Veterinary Drug Market Size by Type (2015-2020)
4.1.1 Global Pet Veterinary Drug Sales by Type (2015-2020)
4.1.2 Global Pet Veterinary Drug Revenue by Type (2015-2020)
4.1.3 Pet Veterinary Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pet Veterinary Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Pet Veterinary Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Pet Veterinary Drug Revenue Forecast by Type (2021-2026)
4.2.3 Pet Veterinary Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pet Veterinary Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Pet Veterinary Drug Market Size by Application (2015-2020)
5.1.1 Global Pet Veterinary Drug Sales by Application (2015-2020)
5.1.2 Global Pet Veterinary Drug Revenue by Application (2015-2020)
5.1.3 Pet Veterinary Drug Price by Application (2015-2020)
5.2 Pet Veterinary Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Pet Veterinary Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Pet Veterinary Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Pet Veterinary Drug Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Pet Veterinary Drug by Country
6.1.1 North America Pet Veterinary Drug Sales by Country
6.1.2 North America Pet Veterinary Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pet Veterinary Drug Market Facts & Figures by Type
6.3 North America Pet Veterinary Drug Market Facts & Figures by Application
7 EUROPE
7.1 Europe Pet Veterinary Drug by Country
7.1.1 Europe Pet Veterinary Drug Sales by Country
7.1.2 Europe Pet Veterinary Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pet Veterinary Drug Market Facts & Figures by Type
7.3 Europe Pet Veterinary Drug Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Pet Veterinary Drug by Region
8.1.1 Asia Pacific Pet Veterinary Drug Sales by Region
8.1.2 Asia Pacific Pet Veterinary Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pet Veterinary Drug Market Facts & Figures by Type
8.3 Asia Pacific Pet Veterinary Drug Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Pet Veterinary Drug by Country
9.1.1 Latin America Pet Veterinary Drug Sales by Country
9.1.2 Latin America Pet Veterinary Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pet Veterinary Drug Market Facts & Figures by Type
9.3 Central & South America Pet Veterinary Drug Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Pet Veterinary Drug by Country
10.1.1 Middle East and Africa Pet Veterinary Drug Sales by Country
10.1.2 Middle East and Africa Pet Veterinary Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pet Veterinary Drug Market Facts & Figures by Type
10.3 Middle East and Africa Pet Veterinary Drug Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Boehringer Ingelheim International GmbH
11.1.1 Boehringer Ingelheim International GmbH Corporation Information
11.1.2 Boehringer Ingelheim International GmbH Description, Business Overview and Total Revenue
11.1.3 Boehringer Ingelheim International GmbH Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Boehringer Ingelheim International GmbH Pet Veterinary Drug Products Offered
11.1.5 Boehringer Ingelheim International GmbH Recent Development
11.2 Zoetis Animal Healthcare
11.2.1 Zoetis Animal Healthcare Corporation Information
11.2.2 Zoetis Animal Healthcare Description, Business Overview and Total Revenue
11.2.3 Zoetis Animal Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Zoetis Animal Healthcare Pet Veterinary Drug Products Offered
11.2.5 Zoetis Animal Healthcare Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Corporation Information
11.3.2 Bayer AG Description, Business Overview and Total Revenue
11.3.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer AG Pet Veterinary Drug Products Offered
11.3.5 Bayer AG Recent Development
11.4 Merck Animal Health
11.4.1 Merck Animal Health Corporation Information
11.4.2 Merck Animal Health Description, Business Overview and Total Revenue
11.4.3 Merck Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Animal Health Pet Veterinary Drug Products Offered
11.4.5 Merck Animal Health Recent Development
11.5 Elanco Animal Health Inc.
11.5.1 Elanco Animal Health Inc. Corporation Information
11.5.2 Elanco Animal Health Inc. Description, Business Overview and Total Revenue
11.5.3 Elanco Animal Health Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Elanco Animal Health Inc. Pet Veterinary Drug Products Offered
11.5.5 Elanco Animal Health Inc. Recent Development
11.6 Virbac Group
11.6.1 Virbac Group Corporation Information
11.6.2 Virbac Group Description, Business Overview and Total Revenue
11.6.3 Virbac Group Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Virbac Group Pet Veterinary Drug Products Offered
11.6.5 Virbac Group Recent Development
11.7 Ceva
11.7.1 Ceva Corporation Information
11.7.2 Ceva Description, Business Overview and Total Revenue
11.7.3 Ceva Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Ceva Pet Veterinary Drug Products Offered
11.7.5 Ceva Recent Development
11.8 Dechra Pharmaceuticals Plc
11.8.1 Dechra Pharmaceuticals Plc Corporation Information
11.8.2 Dechra Pharmaceuticals Plc Description, Business Overview and Total Revenue
11.8.3 Dechra Pharmaceuticals Plc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Dechra Pharmaceuticals Plc Pet Veterinary Drug Products Offered
11.8.5 Dechra Pharmaceuticals Plc Recent Development
11.9 Vetoquinol
11.9.1 Vetoquinol Corporation Information
11.9.2 Vetoquinol Description, Business Overview and Total Revenue
11.9.3 Vetoquinol Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Vetoquinol Pet Veterinary Drug Products Offered
11.9.5 Vetoquinol Recent Development
11.10 Orion Corporation
11.10.1 Orion Corporation Corporation Information
11.10.2 Orion Corporation Description, Business Overview and Total Revenue
11.10.3 Orion Corporation Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Orion Corporation Pet Veterinary Drug Products Offered
11.10.5 Orion Corporation Recent Development
11.1 Boehringer Ingelheim International GmbH
11.1.1 Boehringer Ingelheim International GmbH Corporation Information
11.1.2 Boehringer Ingelheim International GmbH Description, Business Overview and Total Revenue
11.1.3 Boehringer Ingelheim International GmbH Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Boehringer Ingelheim International GmbH Pet Veterinary Drug Products Offered
11.1.5 Boehringer Ingelheim International GmbH Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Pet Veterinary Drug Market Estimates and Projections by Region
12.1.1 Global Pet Veterinary Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Pet Veterinary Drug Revenue Forecast by Regions 2021-2026
12.2 North America Pet Veterinary Drug Market Size Forecast (2021-2026)
12.2.1 North America: Pet Veterinary Drug Sales Forecast (2021-2026)
12.2.2 North America: Pet Veterinary Drug Revenue Forecast (2021-2026)
12.2.3 North America: Pet Veterinary Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Pet Veterinary Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Pet Veterinary Drug Sales Forecast (2021-2026)
12.3.2 Europe: Pet Veterinary Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Pet Veterinary Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pet Veterinary Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pet Veterinary Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pet Veterinary Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pet Veterinary Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Pet Veterinary Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Pet Veterinary Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Pet Veterinary Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Pet Veterinary Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pet Veterinary Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pet Veterinary Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pet Veterinary Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pet Veterinary Drug Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pet Veterinary Drug Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Pet Veterinary Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Pet Veterinary Drug Market Segments
Table 2. Ranking of Global Top Pet Veterinary Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pet Veterinary Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Anti-Infectives
Table 5. Major Manufacturers of Anti-Inflammatory
Table 6. Major Manufacturers of Parasiticides
Table 7. Major Manufacturers of Analgesics
Table 8. Major Manufacturers of Sedatives
Table 9. Major Manufacturers of Others
Table 10. COVID-19 Impact Global Market: (Four Pet Veterinary Drug Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Pet Veterinary Drug Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Pet Veterinary Drug Players to Combat Covid-19 Impact
Table 15. Global Pet Veterinary Drug Market Size Growth Rate by Application 2020-2026 (K Units)
Table 16. Global Pet Veterinary Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 17. Global Pet Veterinary Drug Sales by Regions 2015-2020 (K Units)
Table 18. Global Pet Veterinary Drug Sales Market Share by Regions (2015-2020)
Table 19. Global Pet Veterinary Drug Revenue by Regions 2015-2020 (US$ Million)
Table 20. Global Pet Veterinary Drug Sales by Manufacturers (2015-2020) (K Units)
Table 21. Global Pet Veterinary Drug Sales Share by Manufacturers (2015-2020)
Table 22. Global Pet Veterinary Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 23. Global Pet Veterinary Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Veterinary Drug as of 2019)
Table 24. Pet Veterinary Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 25. Pet Veterinary Drug Revenue Share by Manufacturers (2015-2020)
Table 26. Key Manufacturers Pet Veterinary Drug Price (2015-2020) (USD/Unit)
Table 27. Pet Veterinary Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Pet Veterinary Drug Product Type
Table 29. Date of International Manufacturers Enter into Pet Veterinary Drug Market
Table 30. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 31. Global Pet Veterinary Drug Sales by Type (2015-2020) (K Units)
Table 32. Global Pet Veterinary Drug Sales Share by Type (2015-2020)
Table 33. Global Pet Veterinary Drug Revenue by Type (2015-2020) (US$ Million)
Table 34. Global Pet Veterinary Drug Revenue Share by Type (2015-2020)
Table 35. Pet Veterinary Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 36. Global Pet Veterinary Drug Sales by Application (2015-2020) (K Units)
Table 37. Global Pet Veterinary Drug Sales Share by Application (2015-2020)
Table 38. North America Pet Veterinary Drug Sales by Country (2015-2020) (K Units)
Table 39. North America Pet Veterinary Drug Sales Market Share by Country (2015-2020)
Table 40. North America Pet Veterinary Drug Revenue by Country (2015-2020) (US$ Million)
Table 41. North America Pet Veterinary Drug Revenue Market Share by Country (2015-2020)
Table 42. North America Pet Veterinary Drug Sales by Type (2015-2020) (K Units)
Table 43. North America Pet Veterinary Drug Sales Market Share by Type (2015-2020)
Table 44. North America Pet Veterinary Drug Sales by Application (2015-2020) (K Units)
Table 45. North America Pet Veterinary Drug Sales Market Share by Application (2015-2020)
Table 46. Europe Pet Veterinary Drug Sales by Country (2015-2020) (K Units)
Table 47. Europe Pet Veterinary Drug Sales Market Share by Country (2015-2020)
Table 48. Europe Pet Veterinary Drug Revenue by Country (2015-2020) (US$ Million)
Table 49. Europe Pet Veterinary Drug Revenue Market Share by Country (2015-2020)
Table 50. Europe Pet Veterinary Drug Sales by Type (2015-2020) (K Units)
Table 51. Europe Pet Veterinary Drug Sales Market Share by Type (2015-2020)
Table 52. Europe Pet Veterinary Drug Sales by Application (2015-2020) (K Units)
Table 53. Europe Pet Veterinary Drug Sales Market Share by Application (2015-2020)
Table 54. Asia Pacific Pet Veterinary Drug Sales by Region (2015-2020) (K Units)
Table 55. Asia Pacific Pet Veterinary Drug Sales Market Share by Region (2015-2020)
Table 56. Asia Pacific Pet Veterinary Drug Revenue by Region (2015-2020) (US$ Million)
Table 57. Asia Pacific Pet Veterinary Drug Revenue Market Share by Region (2015-2020)
Table 58. Asia Pacific Pet Veterinary Drug Sales by Type (2015-2020) (K Units)
Table 59. Asia Pacific Pet Veterinary Drug Sales Market Share by Type (2015-2020)
Table 60. Asia Pacific Pet Veterinary Drug Sales by Application (2015-2020) (K Units)
Table 61. Asia Pacific Pet Veterinary Drug Sales Market Share by Application (2015-2020)
Table 62. Latin America Pet Veterinary Drug Sales by Country (2015-2020) (K Units)
Table 63. Latin America Pet Veterinary Drug Sales Market Share by Country (2015-2020)
Table 64. Latin Americaa Pet Veterinary Drug Revenue by Country (2015-2020) (US$ Million)
Table 65. Latin America Pet Veterinary Drug Revenue Market Share by Country (2015-2020)
Table 66. Latin America Pet Veterinary Drug Sales by Type (2015-2020) (K Units)
Table 67. Latin America Pet Veterinary Drug Sales Market Share by Type (2015-2020)
Table 68. Latin America Pet Veterinary Drug Sales by Application (2015-2020) (K Units)
Table 69. Latin America Pet Veterinary Drug Sales Market Share by Application (2015-2020)
Table 70. Middle East and Africa Pet Veterinary Drug Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Pet Veterinary Drug Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Pet Veterinary Drug Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Pet Veterinary Drug Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Pet Veterinary Drug Sales by Type (2015-2020) (K Units)
Table 75. Middle East and Africa Pet Veterinary Drug Sales Market Share by Type (2015-2020)
Table 76. Middle East and Africa Pet Veterinary Drug Sales by Application (2015-2020) (K Units)
Table 77. Middle East and Africa Pet Veterinary Drug Sales Market Share by Application (2015-2020)
Table 78. Boehringer Ingelheim International GmbH Corporation Information
Table 79. Boehringer Ingelheim International GmbH Description and Major Businesses
Table 80. Boehringer Ingelheim International GmbH Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Boehringer Ingelheim International GmbH Product
Table 82. Boehringer Ingelheim International GmbH Recent Development
Table 83. Zoetis Animal Healthcare Corporation Information
Table 84. Zoetis Animal Healthcare Description and Major Businesses
Table 85. Zoetis Animal Healthcare Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Zoetis Animal Healthcare Product
Table 87. Zoetis Animal Healthcare Recent Development
Table 88. Bayer AG Corporation Information
Table 89. Bayer AG Description and Major Businesses
Table 90. Bayer AG Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Bayer AG Product
Table 92. Bayer AG Recent Development
Table 93. Merck Animal Health Corporation Information
Table 94. Merck Animal Health Description and Major Businesses
Table 95. Merck Animal Health Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Merck Animal Health Product
Table 97. Merck Animal Health Recent Development
Table 98. Elanco Animal Health Inc. Corporation Information
Table 99. Elanco Animal Health Inc. Description and Major Businesses
Table 100. Elanco Animal Health Inc. Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Elanco Animal Health Inc. Product
Table 102. Elanco Animal Health Inc. Recent Development
Table 103. Virbac Group Corporation Information
Table 104. Virbac Group Description and Major Businesses
Table 105. Virbac Group Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Virbac Group Product
Table 107. Virbac Group Recent Development
Table 108. Ceva Corporation Information
Table 109. Ceva Description and Major Businesses
Table 110. Ceva Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Ceva Product
Table 112. Ceva Recent Development
Table 113. Dechra Pharmaceuticals Plc Corporation Information
Table 114. Dechra Pharmaceuticals Plc Description and Major Businesses
Table 115. Dechra Pharmaceuticals Plc Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Dechra Pharmaceuticals Plc Product
Table 117. Dechra Pharmaceuticals Plc Recent Development
Table 118. Vetoquinol Corporation Information
Table 119. Vetoquinol Description and Major Businesses
Table 120. Vetoquinol Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Vetoquinol Product
Table 122. Vetoquinol Recent Development
Table 123. Orion Corporation Corporation Information
Table 124. Orion Corporation Description and Major Businesses
Table 125. Orion Corporation Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Orion Corporation Product
Table 127. Orion Corporation Recent Development
Table 128. Global Pet Veterinary Drug Sales Forecast by Regions (2021-2026) (K Units)
Table 129. Global Pet Veterinary Drug Sales Market Share Forecast by Regions (2021-2026)
Table 130. Global Pet Veterinary Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 131. Global Pet Veterinary Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 132. North America: Pet Veterinary Drug Sales Forecast by Country (2021-2026) (K Units)
Table 133. North America: Pet Veterinary Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Europe: Pet Veterinary Drug Sales Forecast by Country (2021-2026) (K Units)
Table 135. Europe: Pet Veterinary Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Asia Pacific: Pet Veterinary Drug Sales Forecast by Region (2021-2026) (K Units)
Table 137. Asia Pacific: Pet Veterinary Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 138. Latin America: Pet Veterinary Drug Sales Forecast by Country (2021-2026) (K Units)
Table 139. Latin America: Pet Veterinary Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Middle East and Africa: Pet Veterinary Drug Sales Forecast by Country (2021-2026) (K Units)
Table 141. Middle East and Africa: Pet Veterinary Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 143. Key Challenges
Table 144. Market Risks
Table 145. Main Points Interviewed from Key Pet Veterinary Drug Players
Table 146. Pet Veterinary Drug Customers List
Table 147. Pet Veterinary Drug Distributors List
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 1. Pet Veterinary Drug Market Segments
Table 2. Ranking of Global Top Pet Veterinary Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pet Veterinary Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Anti-Infectives
Table 5. Major Manufacturers of Anti-Inflammatory
Table 6. Major Manufacturers of Parasiticides
Table 7. Major Manufacturers of Analgesics
Table 8. Major Manufacturers of Sedatives
Table 9. Major Manufacturers of Others
Table 10. COVID-19 Impact Global Market: (Four Pet Veterinary Drug Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Pet Veterinary Drug Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Pet Veterinary Drug Players to Combat Covid-19 Impact
Table 15. Global Pet Veterinary Drug Market Size Growth Rate by Application 2020-2026 (K Units)
Table 16. Global Pet Veterinary Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 17. Global Pet Veterinary Drug Sales by Regions 2015-2020 (K Units)
Table 18. Global Pet Veterinary Drug Sales Market Share by Regions (2015-2020)
Table 19. Global Pet Veterinary Drug Revenue by Regions 2015-2020 (US$ Million)
Table 20. Global Pet Veterinary Drug Sales by Manufacturers (2015-2020) (K Units)
Table 21. Global Pet Veterinary Drug Sales Share by Manufacturers (2015-2020)
Table 22. Global Pet Veterinary Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 23. Global Pet Veterinary Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Veterinary Drug as of 2019)
Table 24. Pet Veterinary Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 25. Pet Veterinary Drug Revenue Share by Manufacturers (2015-2020)
Table 26. Key Manufacturers Pet Veterinary Drug Price (2015-2020) (USD/Unit)
Table 27. Pet Veterinary Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Pet Veterinary Drug Product Type
Table 29. Date of International Manufacturers Enter into Pet Veterinary Drug Market
Table 30. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 31. Global Pet Veterinary Drug Sales by Type (2015-2020) (K Units)
Table 32. Global Pet Veterinary Drug Sales Share by Type (2015-2020)
Table 33. Global Pet Veterinary Drug Revenue by Type (2015-2020) (US$ Million)
Table 34. Global Pet Veterinary Drug Revenue Share by Type (2015-2020)
Table 35. Pet Veterinary Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 36. Global Pet Veterinary Drug Sales by Application (2015-2020) (K Units)
Table 37. Global Pet Veterinary Drug Sales Share by Application (2015-2020)
Table 38. North America Pet Veterinary Drug Sales by Country (2015-2020) (K Units)
Table 39. North America Pet Veterinary Drug Sales Market Share by Country (2015-2020)
Table 40. North America Pet Veterinary Drug Revenue by Country (2015-2020) (US$ Million)
Table 41. North America Pet Veterinary Drug Revenue Market Share by Country (2015-2020)
Table 42. North America Pet Veterinary Drug Sales by Type (2015-2020) (K Units)
Table 43. North America Pet Veterinary Drug Sales Market Share by Type (2015-2020)
Table 44. North America Pet Veterinary Drug Sales by Application (2015-2020) (K Units)
Table 45. North America Pet Veterinary Drug Sales Market Share by Application (2015-2020)
Table 46. Europe Pet Veterinary Drug Sales by Country (2015-2020) (K Units)
Table 47. Europe Pet Veterinary Drug Sales Market Share by Country (2015-2020)
Table 48. Europe Pet Veterinary Drug Revenue by Country (2015-2020) (US$ Million)
Table 49. Europe Pet Veterinary Drug Revenue Market Share by Country (2015-2020)
Table 50. Europe Pet Veterinary Drug Sales by Type (2015-2020) (K Units)
Table 51. Europe Pet Veterinary Drug Sales Market Share by Type (2015-2020)
Table 52. Europe Pet Veterinary Drug Sales by Application (2015-2020) (K Units)
Table 53. Europe Pet Veterinary Drug Sales Market Share by Application (2015-2020)
Table 54. Asia Pacific Pet Veterinary Drug Sales by Region (2015-2020) (K Units)
Table 55. Asia Pacific Pet Veterinary Drug Sales Market Share by Region (2015-2020)
Table 56. Asia Pacific Pet Veterinary Drug Revenue by Region (2015-2020) (US$ Million)
Table 57. Asia Pacific Pet Veterinary Drug Revenue Market Share by Region (2015-2020)
Table 58. Asia Pacific Pet Veterinary Drug Sales by Type (2015-2020) (K Units)
Table 59. Asia Pacific Pet Veterinary Drug Sales Market Share by Type (2015-2020)
Table 60. Asia Pacific Pet Veterinary Drug Sales by Application (2015-2020) (K Units)
Table 61. Asia Pacific Pet Veterinary Drug Sales Market Share by Application (2015-2020)
Table 62. Latin America Pet Veterinary Drug Sales by Country (2015-2020) (K Units)
Table 63. Latin America Pet Veterinary Drug Sales Market Share by Country (2015-2020)
Table 64. Latin Americaa Pet Veterinary Drug Revenue by Country (2015-2020) (US$ Million)
Table 65. Latin America Pet Veterinary Drug Revenue Market Share by Country (2015-2020)
Table 66. Latin America Pet Veterinary Drug Sales by Type (2015-2020) (K Units)
Table 67. Latin America Pet Veterinary Drug Sales Market Share by Type (2015-2020)
Table 68. Latin America Pet Veterinary Drug Sales by Application (2015-2020) (K Units)
Table 69. Latin America Pet Veterinary Drug Sales Market Share by Application (2015-2020)
Table 70. Middle East and Africa Pet Veterinary Drug Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Pet Veterinary Drug Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Pet Veterinary Drug Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Pet Veterinary Drug Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Pet Veterinary Drug Sales by Type (2015-2020) (K Units)
Table 75. Middle East and Africa Pet Veterinary Drug Sales Market Share by Type (2015-2020)
Table 76. Middle East and Africa Pet Veterinary Drug Sales by Application (2015-2020) (K Units)
Table 77. Middle East and Africa Pet Veterinary Drug Sales Market Share by Application (2015-2020)
Table 78. Boehringer Ingelheim International GmbH Corporation Information
Table 79. Boehringer Ingelheim International GmbH Description and Major Businesses
Table 80. Boehringer Ingelheim International GmbH Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Boehringer Ingelheim International GmbH Product
Table 82. Boehringer Ingelheim International GmbH Recent Development
Table 83. Zoetis Animal Healthcare Corporation Information
Table 84. Zoetis Animal Healthcare Description and Major Businesses
Table 85. Zoetis Animal Healthcare Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Zoetis Animal Healthcare Product
Table 87. Zoetis Animal Healthcare Recent Development
Table 88. Bayer AG Corporation Information
Table 89. Bayer AG Description and Major Businesses
Table 90. Bayer AG Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Bayer AG Product
Table 92. Bayer AG Recent Development
Table 93. Merck Animal Health Corporation Information
Table 94. Merck Animal Health Description and Major Businesses
Table 95. Merck Animal Health Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Merck Animal Health Product
Table 97. Merck Animal Health Recent Development
Table 98. Elanco Animal Health Inc. Corporation Information
Table 99. Elanco Animal Health Inc. Description and Major Businesses
Table 100. Elanco Animal Health Inc. Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Elanco Animal Health Inc. Product
Table 102. Elanco Animal Health Inc. Recent Development
Table 103. Virbac Group Corporation Information
Table 104. Virbac Group Description and Major Businesses
Table 105. Virbac Group Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Virbac Group Product
Table 107. Virbac Group Recent Development
Table 108. Ceva Corporation Information
Table 109. Ceva Description and Major Businesses
Table 110. Ceva Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Ceva Product
Table 112. Ceva Recent Development
Table 113. Dechra Pharmaceuticals Plc Corporation Information
Table 114. Dechra Pharmaceuticals Plc Description and Major Businesses
Table 115. Dechra Pharmaceuticals Plc Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Dechra Pharmaceuticals Plc Product
Table 117. Dechra Pharmaceuticals Plc Recent Development
Table 118. Vetoquinol Corporation Information
Table 119. Vetoquinol Description and Major Businesses
Table 120. Vetoquinol Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Vetoquinol Product
Table 122. Vetoquinol Recent Development
Table 123. Orion Corporation Corporation Information
Table 124. Orion Corporation Description and Major Businesses
Table 125. Orion Corporation Pet Veterinary Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Orion Corporation Product
Table 127. Orion Corporation Recent Development
Table 128. Global Pet Veterinary Drug Sales Forecast by Regions (2021-2026) (K Units)
Table 129. Global Pet Veterinary Drug Sales Market Share Forecast by Regions (2021-2026)
Table 130. Global Pet Veterinary Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 131. Global Pet Veterinary Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 132. North America: Pet Veterinary Drug Sales Forecast by Country (2021-2026) (K Units)
Table 133. North America: Pet Veterinary Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Europe: Pet Veterinary Drug Sales Forecast by Country (2021-2026) (K Units)
Table 135. Europe: Pet Veterinary Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Asia Pacific: Pet Veterinary Drug Sales Forecast by Region (2021-2026) (K Units)
Table 137. Asia Pacific: Pet Veterinary Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 138. Latin America: Pet Veterinary Drug Sales Forecast by Country (2021-2026) (K Units)
Table 139. Latin America: Pet Veterinary Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Middle East and Africa: Pet Veterinary Drug Sales Forecast by Country (2021-2026) (K Units)
Table 141. Middle East and Africa: Pet Veterinary Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 143. Key Challenges
Table 144. Market Risks
Table 145. Main Points Interviewed from Key Pet Veterinary Drug Players
Table 146. Pet Veterinary Drug Customers List
Table 147. Pet Veterinary Drug Distributors List
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Pet Veterinary Drug Product Picture
Figure 2. Global Pet Veterinary Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Anti-Infectives Product Picture
Figure 4. Anti-Inflammatory Product Picture
Figure 5. Parasiticides Product Picture
Figure 6. Analgesics Product Picture
Figure 7. Sedatives Product Picture
Figure 8. Others Product Picture
Figure 9. Global Pet Veterinary Drug Sales Market Share by Application in 2020 & 2026
Figure 10. Veterinary Hospitals
Figure 11. Veterinary Clinics
Figure 12. Drug Stores
Figure 13. Pet Veterinary Drug Report Years Considered
Figure 14. Global Pet Veterinary Drug Market Size 2015-2026 (US$ Million)
Figure 15. Global Pet Veterinary Drug Sales 2015-2026 (K Units)
Figure 16. Global Pet Veterinary Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Pet Veterinary Drug Sales Market Share by Region (2015-2020)
Figure 18. Global Pet Veterinary Drug Sales Market Share by Region in 2019
Figure 19. Global Pet Veterinary Drug Revenue Market Share by Region (2015-2020)
Figure 20. Global Pet Veterinary Drug Revenue Market Share by Region in 2019
Figure 21. Global Pet Veterinary Drug Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Pet Veterinary Drug Revenue in 2019
Figure 23. Pet Veterinary Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Pet Veterinary Drug Sales Market Share by Type (2015-2020)
Figure 25. Global Pet Veterinary Drug Sales Market Share by Type in 2019
Figure 26. Global Pet Veterinary Drug Revenue Market Share by Type (2015-2020)
Figure 27. Global Pet Veterinary Drug Revenue Market Share by Type in 2019
Figure 28. Global Pet Veterinary Drug Market Share by Price Range (2015-2020)
Figure 29. Global Pet Veterinary Drug Sales Market Share by Application (2015-2020)
Figure 30. Global Pet Veterinary Drug Sales Market Share by Application in 2019
Figure 31. Global Pet Veterinary Drug Revenue Market Share by Application (2015-2020)
Figure 32. Global Pet Veterinary Drug Revenue Market Share by Application in 2019
Figure 33. North America Pet Veterinary Drug Sales Growth Rate 2015-2020 (K Units)
Figure 34. North America Pet Veterinary Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Pet Veterinary Drug Sales Market Share by Country in 2019
Figure 36. North America Pet Veterinary Drug Revenue Market Share by Country in 2019
Figure 37. U.S. Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 38. U.S. Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 40. Canada Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Pet Veterinary Drug Market Share by Type in 2019
Figure 42. North America Pet Veterinary Drug Market Share by Application in 2019
Figure 43. Europe Pet Veterinary Drug Sales Growth Rate 2015-2020 (K Units)
Figure 44. Europe Pet Veterinary Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Pet Veterinary Drug Sales Market Share by Country in 2019
Figure 46. Europe Pet Veterinary Drug Revenue Market Share by Country in 2019
Figure 47. Germany Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 48. Germany Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 50. France Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.K. Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 54. Italy Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 56. Russia Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Pet Veterinary Drug Market Share by Type in 2019
Figure 58. Europe Pet Veterinary Drug Market Share by Application in 2019
Figure 59. Asia Pacific Pet Veterinary Drug Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Pet Veterinary Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Pet Veterinary Drug Sales Market Share by Region in 2019
Figure 62. Asia Pacific Pet Veterinary Drug Revenue Market Share by Region in 2019
Figure 63. China Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Pet Veterinary Drug Market Share by Type in 2019
Figure 86. Asia Pacific Pet Veterinary Drug Market Share by Application in 2019
Figure 87. Latin America Pet Veterinary Drug Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America Pet Veterinary Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Pet Veterinary Drug Sales Market Share by Country in 2019
Figure 90. Latin America Pet Veterinary Drug Revenue Market Share by Country in 2019
Figure 91. Mexico Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Pet Veterinary Drug Market Share by Type in 2019
Figure 98. Latin America Pet Veterinary Drug Market Share by Application in 2019
Figure 99. Middle East and Africa Pet Veterinary Drug Sales Growth Rate 2015-2020 (K Units)
Figure 100. Middle East and Africa Pet Veterinary Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Pet Veterinary Drug Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Pet Veterinary Drug Revenue Market Share by Country in 2019
Figure 103. Turkey Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 104. Turkey Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 106. Saudi Arabia Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 108. U.A.E Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Pet Veterinary Drug Market Share by Type in 2019
Figure 110. Middle East and Africa Pet Veterinary Drug Market Share by Application in 2019
Figure 111. Boehringer Ingelheim International GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Zoetis Animal Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Merck Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Elanco Animal Health Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Virbac Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Ceva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Dechra Pharmaceuticals Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Vetoquinol Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Orion Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America Pet Veterinary Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. North America Pet Veterinary Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe Pet Veterinary Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Europe Pet Veterinary Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific Pet Veterinary Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. Asia Pacific Pet Veterinary Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America Pet Veterinary Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 128. Latin America Pet Veterinary Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa Pet Veterinary Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 130. Middle East and Africa Pet Veterinary Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for This Report
Figure 135. Data Triangulation
Figure 136. Key Executives Interviewed
Figure 1. Pet Veterinary Drug Product Picture
Figure 2. Global Pet Veterinary Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Anti-Infectives Product Picture
Figure 4. Anti-Inflammatory Product Picture
Figure 5. Parasiticides Product Picture
Figure 6. Analgesics Product Picture
Figure 7. Sedatives Product Picture
Figure 8. Others Product Picture
Figure 9. Global Pet Veterinary Drug Sales Market Share by Application in 2020 & 2026
Figure 10. Veterinary Hospitals
Figure 11. Veterinary Clinics
Figure 12. Drug Stores
Figure 13. Pet Veterinary Drug Report Years Considered
Figure 14. Global Pet Veterinary Drug Market Size 2015-2026 (US$ Million)
Figure 15. Global Pet Veterinary Drug Sales 2015-2026 (K Units)
Figure 16. Global Pet Veterinary Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Pet Veterinary Drug Sales Market Share by Region (2015-2020)
Figure 18. Global Pet Veterinary Drug Sales Market Share by Region in 2019
Figure 19. Global Pet Veterinary Drug Revenue Market Share by Region (2015-2020)
Figure 20. Global Pet Veterinary Drug Revenue Market Share by Region in 2019
Figure 21. Global Pet Veterinary Drug Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Pet Veterinary Drug Revenue in 2019
Figure 23. Pet Veterinary Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Pet Veterinary Drug Sales Market Share by Type (2015-2020)
Figure 25. Global Pet Veterinary Drug Sales Market Share by Type in 2019
Figure 26. Global Pet Veterinary Drug Revenue Market Share by Type (2015-2020)
Figure 27. Global Pet Veterinary Drug Revenue Market Share by Type in 2019
Figure 28. Global Pet Veterinary Drug Market Share by Price Range (2015-2020)
Figure 29. Global Pet Veterinary Drug Sales Market Share by Application (2015-2020)
Figure 30. Global Pet Veterinary Drug Sales Market Share by Application in 2019
Figure 31. Global Pet Veterinary Drug Revenue Market Share by Application (2015-2020)
Figure 32. Global Pet Veterinary Drug Revenue Market Share by Application in 2019
Figure 33. North America Pet Veterinary Drug Sales Growth Rate 2015-2020 (K Units)
Figure 34. North America Pet Veterinary Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Pet Veterinary Drug Sales Market Share by Country in 2019
Figure 36. North America Pet Veterinary Drug Revenue Market Share by Country in 2019
Figure 37. U.S. Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 38. U.S. Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 40. Canada Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Pet Veterinary Drug Market Share by Type in 2019
Figure 42. North America Pet Veterinary Drug Market Share by Application in 2019
Figure 43. Europe Pet Veterinary Drug Sales Growth Rate 2015-2020 (K Units)
Figure 44. Europe Pet Veterinary Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Pet Veterinary Drug Sales Market Share by Country in 2019
Figure 46. Europe Pet Veterinary Drug Revenue Market Share by Country in 2019
Figure 47. Germany Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 48. Germany Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 50. France Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.K. Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 54. Italy Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 56. Russia Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Pet Veterinary Drug Market Share by Type in 2019
Figure 58. Europe Pet Veterinary Drug Market Share by Application in 2019
Figure 59. Asia Pacific Pet Veterinary Drug Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Pet Veterinary Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Pet Veterinary Drug Sales Market Share by Region in 2019
Figure 62. Asia Pacific Pet Veterinary Drug Revenue Market Share by Region in 2019
Figure 63. China Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Pet Veterinary Drug Market Share by Type in 2019
Figure 86. Asia Pacific Pet Veterinary Drug Market Share by Application in 2019
Figure 87. Latin America Pet Veterinary Drug Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America Pet Veterinary Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Pet Veterinary Drug Sales Market Share by Country in 2019
Figure 90. Latin America Pet Veterinary Drug Revenue Market Share by Country in 2019
Figure 91. Mexico Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Pet Veterinary Drug Market Share by Type in 2019
Figure 98. Latin America Pet Veterinary Drug Market Share by Application in 2019
Figure 99. Middle East and Africa Pet Veterinary Drug Sales Growth Rate 2015-2020 (K Units)
Figure 100. Middle East and Africa Pet Veterinary Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Pet Veterinary Drug Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Pet Veterinary Drug Revenue Market Share by Country in 2019
Figure 103. Turkey Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 104. Turkey Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 106. Saudi Arabia Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Pet Veterinary Drug Sales Growth Rate (2015-2020) (K Units)
Figure 108. U.A.E Pet Veterinary Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Pet Veterinary Drug Market Share by Type in 2019
Figure 110. Middle East and Africa Pet Veterinary Drug Market Share by Application in 2019
Figure 111. Boehringer Ingelheim International GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Zoetis Animal Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Merck Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Elanco Animal Health Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Virbac Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Ceva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Dechra Pharmaceuticals Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Vetoquinol Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Orion Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America Pet Veterinary Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. North America Pet Veterinary Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe Pet Veterinary Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Europe Pet Veterinary Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific Pet Veterinary Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. Asia Pacific Pet Veterinary Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America Pet Veterinary Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 128. Latin America Pet Veterinary Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa Pet Veterinary Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 130. Middle East and Africa Pet Veterinary Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for This Report
Figure 135. Data Triangulation
Figure 136. Key Executives Interviewed
